SEARCH RESULTS FOR:

Mining
Chile

Ramón Opazo

CEO, ANTIRION
Chile Mining 2018 Expomin Official Investment Guide
Antirion provides risk management services through a web-based software platform.
Mining
Mexico
Steel

Ana Karla Garza & Paul Capone

AKG: President, Looper & PC: Sales, Kosmos Logistics
Mexico Steel and Iron 2018
Kosmos logistics is growing with Mexico’s rapidly developing manufacturing sector, particularly servicing the automotive industry.
United States
Pharma & Life Sciences

Joseph Colleluori

SENIOR VICE PRESIDENT CORPORATE DEVELOPMENT, LONZA GROUP
United States Biopharmaceuticals 2018
Headquartered in Switzerland and traded on the Swiss stock exchange, Lonza is a leading supplier to the pharma and biotech industries.
Pharma & Life Sciences
China

Ningling Wang

MANAGING PARTNER, FINNEGAN
Finnegan in Shanghai helps Chinese companies protect and enforce their IP in the US and also helps foreign clients with patent litigation in China.
Petrochemicals & Chemicals
Singapore

Terence Koh

EXECUTIVE DIRECTOR, SINGAPORE CHEMICAL INDUSTRY COUNCIL (SCIC)
Singapore Chemicals 2018
The Singapore Chemical Industry Council (SCIC) discusses its objectives for the year.
Pharma & Life Sciences
China

Greg Scott

CEO, CHINABIO CONSULTING
ChinaBio morphed from being an angel investor in China to becoming a consultant for foreign compa-nies looking to enter the Chinese life science space.
Aerospace
Canada

Safety First

Québec Aerospace 2017
Optimizing inspection, testing and maintenance measures are a crucial aspect of Canada’s aerospace industry.
Aerospace
France

Michael Niemaz

KEY ACCOUNT MANAGER AEROSPACE, MDP- MAXON MOTOR FRANCE
Maxon Motor Group is a world leader in the design and manufacture of high precision DC motors. Within the group, MDP - Maxon Motor France is specialized in the development of specific mechatronic actuators.
United States
Pharma & Life Sciences

Brian Frenzel

PRESIDENT AND CEO, TOSK, INC.
United States Biopharmaceuticals 2018
Tosk, Inc. is a small molecule, oncology drug discovery and development company.
United States
Pharma & Life Sciences

Finding Funding: The Diversification of the Biotech Financing Landscape

United States Biopharmaceuticals 2018
The methods of financing biotech R&D are evolving as large pharma companies and governments look to small biotech start-ups to provide the next generation of medicines.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL